Richard Vehe
Pediatric Rheumatology · Minneapolis, MNNPI 1972604981
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 2 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, Swedish Orphan Biovitrum AB.
Across 2 payments — averaging $18.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Swedish Orphan Biovitrum AB$38
Across 49 payments — averaging $11,168 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$442K
- Pfizer$81K
- Novartis$16K
- Swedish Orphan Biovitrum AB$8K
What the payments were for
- Food & beverage$38100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Swedish Orphan Biovitrum AB | 2 | $38 |
How this compares
Too few pediatric rheumatology providers in Minnesotato place this figure against a meaningful peer group, so we don't.
Other pediatric rheumatology in Minneapolis
- Zachary ShaheenMinneapolis$50K
- Mona RiskallaMinneapolis$6K
- Bryce BinstadtMinneapolis$221
- Colleen CorrellMinneapolis$0
- Elizabeth ChalomSaint Paul$5K
- Dori AbelRochester$32
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.